Pulmonary vascular diseases

State of the art session
Chairs: T. Troosters (Leuven, Belgium), M. Delcroix (Leuven, Belgium)
Aims: To describe current therapeutic approaches in pulmonary hypertension and to evaluate whether better knowledge of the side effects of drugs can enhance disease prevention.

Drug-related pulmonary hypertension: new threats? D. Montani (Le Kremlin-Bicêtre, France)
PROs: which instruments are available in pulmonary hypertension? J. Pepke-Zaba (Cambridge, United Kingdom)
The metabolic syndrome and pulmonary hypertension A. Hemnes (Nashville, United States of America)
Novel insights into the pathogenesis of pulmonary arterial hypertension M. Humbert (Le Kremlin-Bicêtre, France)